Pilates Exercises Versus Intermittent Fasting Diet on Physical and Metabolic Aging Process in Obese Perimenopausal Women
Effect of Pilates Exercises Versus Intermittent Fasting Diet on Physical and Metabolic Aging Process in Obese Perimenopausal Women
1 other identifier
interventional
50
1 country
1
Brief Summary
This study aims to compare the effect of pilates exercises versus intermittent fasting diet on physical and metabolic aging parameters in obese perimenopausal women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable obesity
Started Jul 2026
Shorter than P25 for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 28, 2026
CompletedStudy Start
First participant enrolled
July 1, 2026
CompletedFirst Posted
Study publicly available on registry
July 6, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 16, 2027
July 6, 2026
June 1, 2026
6 months
June 28, 2026
June 28, 2026
Conditions
Outcome Measures
Primary Outcomes (8)
Body weight
Weight will be measured in kilograms by weight-height scale for all participants before and after treatment program.
12 weeks
Body mass index
It will be measured by weight-height scale by dividing body weight in kilograms by height meter square.
12 weeks
Waist circumference
The waist circumference will be measured in centimeters at the narrowest point between xipho-sternum and the iliac crest at the end of a gentle expiration.
12 weeks
Hip circumference
Hip circumference will be measured in centimeters at the maximum circumference at the level of the femoral trochanter.
12 weeks
Waist-hip ratio
It will be calculated by dividing waist circumference by hip circumference for all participants before and after treatment.
12 weeks
Resting Heart Rate Measurement
Resting heart rate (RHR) is the number of heartbeats per minute (bpm) when a person is at complete rest. It is a simple indicator of cardiovascular health. it will be measured by pulse oximeter. Normal Range: Adults: 60-100 bpm
12 weeks
Maximum Heart Rate
It will be calculated through equation: 220- age
12 weeks
Maximum oxygen consumption (VO2 max)
It will be calculated through the equation:VO2 max = 15.3 x (maximum heart rate / resting heart rate).
12 weeks
Secondary Outcomes (6)
Assessment of the health-related quality of life
12 weeks
Total cholesterol (TC)
12 weeks
Triglycerides
Normal: <150 mg/dL (<1.7 mmol/L)
High-density lipoprotein
12 weeks
Low-density lipoprotein
12 weeks
- +1 more secondary outcomes
Study Arms (2)
Pilates exercise group
EXPERIMENTALThe participants will be treated with Pilates exercises, 4 times per week, 60 minutes per session, for 12 weeks.
Intermittent Fasting Diet
EXPERIMENTALThe participants will follow intermittent fasting diet for 12 weeks.
Interventions
Each exercise will be ranged from 1 to 3 minutes, with a break of 10 seconds. The exercises include: Flat Abs: Pilates Hundred; Flat Abs: Roll-Up; Obliques: Twist and Reach; Lower Back: Shoulder Bridge; Lower Body: Kneeling Side Kicks; Lower Body: Leg Swings; Stamina: Wall Chair.
This fasting regimen involves fasting for 16 hours each day and limiting eating to an 8-hour window. The 16:8 intermittent fasting protocol is relatively straightforward. It divides the day into two main periods: the fasting period which is 16 hours and the 8 hours eating window .
Eligibility Criteria
You may qualify if:
- Their body mass index will be ranged from 30 to 35 kg/m2.
- Waist hip ratio will be \> 1.
- Total cholesterol (TC) will be \> 200 mg/dl.
- Triglycerides (TG) will be \> 150 mg/dl.
- Low-density lipoprotein (LDL) will be \> 100 mg/dl.
- High-density lipoprotein (HDL) will be \< 40 mg/dl.
You may not qualify if:
- Diabetes type I.
- Concomitant cardiac disorders.
- Pregnant or breastfeeding.
- Eating disorders as Anorexia.
- Thyroid disorders.
- Kidney disorders.
- Severe joint issues as arthritis and post-joint replacement.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Hadeel Adil Mohamed
Al Fayyum, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Doaa Osman, As Professor
Cairo University
- STUDY CHAIR
Mohamed Awad, Professor
Cairo University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
June 28, 2026
First Posted
July 6, 2026
Study Start
July 1, 2026
Primary Completion (Estimated)
January 1, 2027
Study Completion (Estimated)
January 16, 2027
Last Updated
July 6, 2026
Record last verified: 2026-06